Fox Run Management L.L.C. Purchases New Position in Wright Medical Group N.V. (NASDAQ:WMGI)

Fox Run Management L.L.C. bought a new stake in Wright Medical Group N.V. (NASDAQ:WMGI) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 14,300 shares of the medical device company’s stock, valued at approximately $370,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Blue Jay Capital Management LLC lifted its stake in shares of Wright Medical Group N.V. by 4.7% in the 2nd quarter. Blue Jay Capital Management LLC now owns 320,420 shares of the medical device company’s stock valued at $8,808,000 after purchasing an additional 14,255 shares during the period. Victory Capital Management Inc. lifted its stake in shares of Wright Medical Group N.V. by 30.6% in the 2nd quarter. Victory Capital Management Inc. now owns 1,039,308 shares of the medical device company’s stock valued at $28,571,000 after purchasing an additional 243,630 shares during the period. Capital Research Global Investors raised its stake in Wright Medical Group N.V. by 60.9% during the second quarter. Capital Research Global Investors now owns 2,775,000 shares of the medical device company’s stock valued at $76,285,000 after buying an additional 1,050,000 shares during the last quarter. Northern Trust Corp raised its stake in Wright Medical Group N.V. by 3.4% during the second quarter. Northern Trust Corp now owns 1,865,977 shares of the medical device company’s stock valued at $51,296,000 after buying an additional 60,840 shares during the last quarter. Finally, Westfield Capital Management Co. LP raised its stake in Wright Medical Group N.V. by 13.8% during the second quarter. Westfield Capital Management Co. LP now owns 2,425,566 shares of the medical device company’s stock valued at $66,679,000 after buying an additional 293,687 shares during the last quarter.

Shares of Wright Medical Group N.V. (NASDAQ WMGI) traded down $0.36 during midday trading on Friday, reaching $23.72. The company’s stock had a trading volume of 723,800 shares, compared to its average volume of 1,029,835. Wright Medical Group N.V. has a 52 week low of $22.14 and a 52 week high of $31.53. The company has a current ratio of 1.31, a quick ratio of 0.96 and a debt-to-equity ratio of 1.52.

Wright Medical Group N.V. (NASDAQ:WMGI) last released its earnings results on Wednesday, November 1st. The medical device company reported ($0.16) EPS for the quarter, meeting analysts’ consensus estimates of ($0.16). Wright Medical Group N.V. had a negative return on equity of 6.27% and a negative net margin of 38.40%. The firm had revenue of $170.50 million for the quarter, compared to analysts’ expectations of $173.50 million. During the same quarter in the prior year, the firm posted ($0.19) earnings per share. The company’s quarterly revenue was up 8.4% on a year-over-year basis. analysts predict that Wright Medical Group N.V. will post -0.27 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of United States & international copyright law. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2017/11/12/fox-run-management-l-l-c-buys-shares-of-14300-wright-medical-group-n-v-wmgi.html.

A number of brokerages have issued reports on WMGI. Jefferies Group LLC reiterated a “buy” rating on shares of Wright Medical Group N.V. in a research note on Friday, November 3rd. Royal Bank Of Canada reissued a “buy” rating and issued a $30.00 target price on shares of Wright Medical Group N.V. in a report on Thursday, November 2nd. Barclays PLC cut their price objective on Wright Medical Group N.V. from $33.00 to $30.00 and set an “overweight” rating for the company in a report on Thursday, November 2nd. BMO Capital Markets cut their price objective on Wright Medical Group N.V. from $34.00 to $31.00 and set an “outperform” rating for the company in a report on Thursday, November 2nd. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Wright Medical Group N.V. in a report on Thursday, November 2nd. Six equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Wright Medical Group N.V. currently has an average rating of “Buy” and an average target price of $32.22.

Wright Medical Group N.V. Profile

Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.

Institutional Ownership by Quarter for Wright Medical Group N.V. (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply